Moderna, Inc. (MRNA) shares fell 7.51% in a single trading session.
The stock price closed at $63.15.
President Stephen Hoge sold approximately $3.6 million in company stock.
The transaction took place on July 15, 2026.
Hoge executed the sale under a pre-arranged Rule 10b5-1 trading plan.
Ongoing patent litigation and the insider sale drove the stock's price volatility.